Logo image of MBI

MBIA INC (MBI) Stock Fundamental Analysis

NYSE:MBI - New York Stock Exchange, Inc. - US55262C1009 - Common Stock - Currency: USD

4.48  +0.05 (+1.13%)

After market: 4.48 0 (0%)

Fundamental Rating

1

MBI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 145 industry peers in the Insurance industry. MBI may be in some trouble as it scores bad on both profitability and health. MBI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MBI has reported negative net income.
MBI had a negative operating cash flow in the past year.
MBI had negative earnings in each of the past 5 years.
MBI had negative operating cash flow in 4 of the past 5 years.
MBI Yearly Net Income VS EBIT VS OCF VS FCFMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

1.2 Ratios

MBI has a Return On Assets of -19.84%. This is amonst the worse of the industry: MBI underperforms 95.17% of its industry peers.
Industry RankSector Rank
ROA -19.84%
ROE N/A
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI Yearly ROA, ROE, ROICMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI Yearly Profit, Operating, Gross MarginsMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, MBI has more shares outstanding
MBI has less shares outstanding than it did 5 years ago.
MBI has a worse debt/assets ratio than last year.
MBI Yearly Shares OutstandingMBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
MBI Yearly Total Debt VS Total AssetsMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MBI Yearly LT Debt VS Equity VS FCFMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBI Yearly Current Assets VS Current LiabilitesMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.59% over the past year.
MBI shows a strong growth in Revenue. In the last year, the Revenue has grown by 168.75%.
The Revenue for MBI have been decreasing by -34.49% on average. This is quite bad
EPS 1Y (TTM)12.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)168.75%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%-33.33%

3.2 Future

MBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.76% yearly.
Based on estimates for the next years, MBI will show a very negative growth in Revenue. The Revenue will decrease by -13.40% on average per year.
EPS Next Y85.58%
EPS Next 2Y35.88%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue Next Year-14.29%
Revenue Next 2Y-13.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBI Yearly Revenue VS EstimatesMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MBI Yearly EPS VS EstimatesMBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI Price Earnings VS Forward Price EarningsMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI Per share dataMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

A more expensive valuation may be justified as MBI's earnings are expected to grow with 22.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.88%
EPS Next 3Y22.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MBI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MBIA INC

NYSE:MBI (7/14/2025, 7:00:00 PM)

After market: 4.48 0 (0%)

4.48

+0.05 (+1.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners48.73%
Inst Owner Change0%
Ins Owners10.58%
Ins Owner Change-3.58%
Market Cap225.66M
Analysts74.29
Price Target6.63 (47.99%)
Short Float %4.81%
Short Ratio8.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend7.73
Dividend Growth(5Y)97.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.98%
Min EPS beat(2)-90.1%
Max EPS beat(2)-21.86%
EPS beat(4)1
Avg EPS beat(4)-456.54%
Min EPS beat(4)-1814.19%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-502.33%
EPS beat(12)4
Avg EPS beat(12)-330.33%
EPS beat(16)5
Avg EPS beat(16)-287.65%
Revenue beat(2)1
Avg Revenue beat(2)32.01%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)65.02%
Revenue beat(4)3
Avg Revenue beat(4)26.12%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)65.02%
Revenue beat(8)7
Avg Revenue beat(8)25.65%
Revenue beat(12)11
Avg Revenue beat(12)116.98%
Revenue beat(16)14
Avg Revenue beat(16)130.99%
PT rev (1m)0%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-109.53%
EPS NY rev (1m)-6.37%
EPS NY rev (3m)10.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.54
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-3.75
FCFYN/A
OCF(TTM)-3.75
OCFYN/A
SpS0.85
BVpS-41.95
TBVpS-41.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y85.58%
EPS Next 2Y35.88%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue 1Y (TTM)168.75%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%-33.33%
Revenue Next Year-14.29%
Revenue Next 2Y-13.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74%
OCF growth 3YN/A
OCF growth 5YN/A